Strategic Insights. Real Impacts.
Tidball BioStrategy provides strategic advisory services to organizations across the biotechnology and life sciences ecosystem, helping translate scientific innovation into practical development and commercialization strategies. The firm advises academic institutions, biotechnology companies, pharmaceutical organizations, investors and other advisory firms on platform evaluation, therapeutic development strategy, and the operational considerations required to advance next-generation therapeutics. Through independent, grounded insight, Tidball BioStrategy supports organizations navigating the complex landscape of modern biotechnology and advanced therapeutic development.
Strategic advisory services to meet the unique needs of biotechnology and life sciences organizations, stakeholders and investors.
One Time Consultations
Schedule a meeting to discuss your program, its trajectory, challenges and ultimately guiding solutions.
Regular Project Support
Sometimes it takes more than one or two meetings to chart the right course and the landscape is ever changing. Let’s continue our work together to find the right path to be on.
Bespoke Services
Looking for something more? Let’s tailor our work together to fit the unique needs of your organization, program or capacity.
Insights built on over a decade in the lab and at the negotiation table.
Wesley D. Tidball, MBA
Founder & Principal | Tidball BioStrategy
Wesley is the Founder and Principal of Tidball BioStrategy, a strategic advisory practice focused on biotechnology, advanced therapeutics, and the evolving landscape of regenerative medicine and cell therapy. He advises biotechnology companies, investors, and advisory firms on commercial strategy, platform development, and the translation of emerging biological technologies into scalable therapeutic solutions.
Wesley’s experience spans the intersection of scientific innovation, biotechnology commercialization, and advanced therapeutic manufacturing, with particular expertise in next-generation cell therapies, gene editing technologies, regenerative medicine, gene therapies, nucleic acids and other emerging modalities. Over the course of his career, he has worked across the biotechnology ecosystem with academic and research institutions, early-stage biotechnology startups, clinical-stage biotechnology companies, and large pharmaceutical organizations.
His work has supported organizations headquartered across Asia-Pacific (APAC), the United States, Canada, Europe, and the Middle East, providing strategic insight across diverse regulatory environments, research ecosystems, and biotechnology markets.
In addition to strategic advisory work, Wesley has extensive experience supporting complex commercial and research collaborations, including the negotiation and structuring of agreements such as Licensing Agreements, Master Services Agreements (MSAs), Material Transfer Agreements (MTAs), research collaboration agreements, and other strategic partnerships that underpin biotechnology development and commercialization.
Through his advisory work, Wesley supports organizations navigating the translational, operational and commercial challenges associated with advanced therapies and emerging therapeutic modalities. His work frequently involves evaluating platform technologies, assessing development and manufacturing strategies, and advising on pathways to translate innovative biological approaches from discovery through clinical development and eventual commercialization.
Wesley holds a Bachelor of Science in Biology from the University of Dayton and an MBA from the Carl H. Lindner College of Business at the University of Cincinnati. His academic training combines a foundation in the life sciences with formal business education, supporting his work at the intersection of biotechnology innovation, strategy, and commercialization.
Wesley founded Tidball BioStrategy to provide independent, commercially grounded strategic insight to organizations developing the next generation of biotechnology and therapeutic innovation.